Shares of Nutriband Inc. (NASDAQ:NTRBW – Get Free Report) rose 3.9% during mid-day trading on Monday . The stock traded as high as $1.60 and last traded at $1.60. Approximately 203 shares were traded during trading, a decline of 98% from the average daily volume of 10,030 shares. The stock had previously closed at $1.54.
Nutriband Trading Up 3.9%
The business has a 50-day moving average of $1.78 and a 200-day moving average of $1.84.
Hedge Funds Weigh In On Nutriband
A hedge fund recently raised its stake in Nutriband stock. Citadel Advisors LLC raised its position in Nutriband Inc. (NASDAQ:NTRBW – Free Report) by 8.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 126,392 shares of the company’s stock after purchasing an additional 9,801 shares during the period. Citadel Advisors LLC’s holdings in Nutriband were worth $190,000 as of its most recent filing with the Securities and Exchange Commission.
About Nutriband
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
Featured Stories
- Five stocks we like better than Nutriband
- Why Invest in 5G? How to Invest in 5G Stocks
- Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Value vs Growth Ratio Hits Cycle Low—Top Value Picks to Buy
- What Are Dividend Champions? How to Invest in the Champions
- Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
